Santex won the tender to buy the Moscow Experimental Vitamin Factory with a pledge to invest more than $10 million, almost twice as much as the $5.1 million minimum set by the Federal Bankruptcy Agency, Interfax said. Santex now has one month to repay the 360 million rubles ($116,000) the plant owes to its creditors and must continue to produce medications, the agency reported.
The factory was one of three bankrupt state firms taken over last August in the government's first attempt to force the restructuring and sell-off of insolvent enterprises.
Officials at the time said the move was the first step toward widespread closures of obsolete enterprises, which experts say could bring the deep economic restructuring the country sorely needs, but could also lead to mass layoffs and social unrest.
A Message from The Moscow Times:
Dear readers,
We are facing unprecedented challenges. Russia's Prosecutor General's Office has designated The Moscow Times as an "undesirable" organization, criminalizing our work and putting our staff at risk of prosecution. This follows our earlier unjust labeling as a "foreign agent."
These actions are direct attempts to silence independent journalism in Russia. The authorities claim our work "discredits the decisions of the Russian leadership." We see things differently: we strive to provide accurate, unbiased reporting on Russia.
We, the journalists of The Moscow Times, refuse to be silenced. But to continue our work, we need your help.
Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and every contribution makes a significant impact.
By supporting The Moscow Times, you're defending open, independent journalism in the face of repression. Thank you for standing with us.
Remind me later.